These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15106308)

  • 1. [Antimicrobial effect of levofloxacin].
    Mitrokhin SD
    Antibiot Khimioter; 2003; 48(11):23-30. PubMed ID: 15106308
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy and safety of levofloxacin in low respiratory tract infection].
    Zubkov MN
    Antibiot Khimioter; 2004; 49(5):31-7. PubMed ID: 15573900
    [No Abstract]   [Full Text] [Related]  

  • 3. Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy.
    Scoper SV
    Adv Ther; 2008 Oct; 25(10):979-94. PubMed ID: 18836691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Levofloxacin nowadays].
    Sidirenko SV
    Antibiot Khimioter; 2006; 51(1):28-37. PubMed ID: 16734363
    [No Abstract]   [Full Text] [Related]  

  • 5. Levofloxacin disk potency and tentative interpretive criteria for susceptibility tests.
    Pfaller MA; Barry AL; Fuchs PC
    J Clin Microbiol; 1993 Jul; 31(7):1924-6. PubMed ID: 8349777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Polymer Complexes of Ofloxacin and Their Antibacterial Activity].
    Ananyeva EP; Baranov SS; Karavaeva AV; Borisenko MS; Solovskiy MV; Zacharova NV; Prazdnikova TA; Tarabukina EB
    Antibiot Khimioter; 2014; 59(11-12):3-6. PubMed ID: 26448985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
    Drugs Exp Clin Res; 1987; 13(9):555-61. PubMed ID: 3480796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Levofloxacin and other antibacterial drugs].
    Ivanov DV; Budanov SV
    Antibiot Khimioter; 2006; 51(6):27-37. PubMed ID: 17523419
    [No Abstract]   [Full Text] [Related]  

  • 9. The bactericidal activity of ofloxacin against staphylococci.
    Lewin CS; Smith JT
    J Chemother; 1989 Jul; 1(4 Suppl):151-3. PubMed ID: 16312348
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
    Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
    Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prulifloxacin versus levofloxacin in the treatment of respiratory and urinary tract infections: a multicentre, double-blind, randomized controlled clinical trial.
    Chen Y; Yang H; Lu G; Wu X; Huang W; Wu Y; Lv X; Wu G; Zhang G; Li Q; Sun Y
    Chemotherapy; 2012; 58(3):249-56. PubMed ID: 22890091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antibacterial evaluation of typharin analog: 6,8-dihydroxy-7-methyl-3-styryl-3,4-dihydroisocoumarin.
    Saeed A; Rafique H; Ashraf Z
    J Asian Nat Prod Res; 2013; 15(2):130-5. PubMed ID: 23323839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of levofloxacin against recent Gram-negative nosocomial pathogens.
    Lanzafame A; Bonfiglio G; Santini L; Mattina R
    Chemotherapy; 2005 Mar; 51(1):44-50. PubMed ID: 15767745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of levofloxacin alone and in combination with a DnaK inhibitor against gram-negative rods, including levofloxacin-resistant strains.
    Credito K; Lin G; Koeth L; Sturgess MA; Appelbaum PC
    Antimicrob Agents Chemother; 2009 Feb; 53(2):814-7. PubMed ID: 19015359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Levofloxacin (Tavanic)--a novel quinolone of the III generation. Antimicrobial activity, pharmacokinetics, clinical significance].
    Budanov SV; Smirnova LB
    Antibiot Khimioter; 2001; 46(5):31-8. PubMed ID: 11558453
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
    Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C
    Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coadministration of oral levofloxacin with agents that impair its absorption: potential impact on emergence of resistance.
    Quain RD; Barton TD; Fishman NO; Weiner MG; Lautenbach E
    Int J Antimicrob Agents; 2005 Oct; 26(4):327-30. PubMed ID: 16154325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antimicrobial activity and action mechanism of ofloxacin].
    Padeĭskaia EN
    Antibiot Khimioter; 1996; 41(9):13-23. PubMed ID: 9005780
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and in vitro activity of a series 1beta-methylcarbapenem derivatives.
    Jeon HC; Kim JW; Hong JH; Cho JH; Oh CH
    Eur J Med Chem; 2006 Oct; 41(10):1201-9. PubMed ID: 16797791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibilities of clinical isolates of HACEK organisms.
    Coburn B; Toye B; Rawte P; Jamieson FB; Farrell DJ; Patel SN
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1989-91. PubMed ID: 23403420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.